Annual report
7376.TEDINET S100XC7N
Period2024-10-01 → 2025-09-30
Filed2025-12-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 86
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.5bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥98m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥18m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥92m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥6m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥66m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥113m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥104m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥92,000 | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥74m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥6m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥45m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥32m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥76m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.0bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥909m | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥915m | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥830m | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥813m | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥450m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥268m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥569m | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥642m | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥647m | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥613m | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥575m | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥599m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥577m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥599m | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥577m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥643m | at 2023-09-30v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥597m | at 2022-09-30v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥615m | at 2021-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥94m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥36m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥88m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥627,000 | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥135m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥56m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥27m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥45m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥172m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥2m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥3m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥217m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-66.23 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.24 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.85 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.11 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.99 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.64 | 2022-10-01 → 2023-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.45 | 2021-10-01 → 2022-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.75 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥511.3 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥577.25 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥582.38 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥550.42 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥520.37 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.8% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -12.2% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.9% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,119,740 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,119,740 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,119,740 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,113,800 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,105,520 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 242 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 232 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 200 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 191 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 173 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-09-30 | 3 pure |
| Otherother segments | depreciation | 2024-10-01 → 2025-09-30 | ¥8,000 |
| Otherother segments | revenue | 2024-10-01 → 2025-09-30 | ¥9m |
| Otherother segments | revenue external | 2024-10-01 → 2025-09-30 | ¥9m |
| Otherother segments | segment assets | at 2025-09-30 | ¥8m |
| Otherother segments | segment profit | 2024-10-01 → 2025-09-30 | −¥63m |
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥525,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-09-30 | ¥759m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥217m |
| Health Care Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥11m |
| Health Care Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥229,000 |
| Health Care Businessreportable segment | employees | at 2025-09-30 | 19 pure |
| Health Care Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥164m |
| Health Care Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥164m |
| Health Care Businessreportable segment | segment assets | at 2025-09-30 | ¥42m |
| Health Care Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥8m |
| IT Sales Outsourcing Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | employees | at 2025-09-30 | 208 pure |
| IT Sales Outsourcing Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥1.3bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥1.3bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2025-09-30 | ¥210m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥190m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-10-01 → 2025-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-10-01 → 2025-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-09-30 | ¥260m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-09-30 | ¥119m |
| Otherother segments | revenue | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | revenue external | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | segment assets | at 2024-09-30 | ¥490,000 |
| Otherother segments | segment profit | 2023-10-01 → 2024-09-30 | −¥21m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥410,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | ¥698m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥189m |
| Health Care Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥1m |
| Health Care Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥227,000 |
| Health Care Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | segment assets | at 2024-09-30 | ¥35m |
| Health Care Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥18m |
| IT Sales Outsourcing Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| IT Sales Outsourcing Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2024-09-30 | ¥176m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥210m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥212m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥171m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 961
| Item | Context | Value | Unit |
|---|---|---|---|
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reduction entry (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding increased due to business transfer main breakdown of assets and liabilities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes equity in earnings losses of affiliates if equity method is applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |